Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

作者：Alicia T. Widge, Nadine Rouphael, Lisa A. Jackson, Evan J. Anderson, Paul C. Roberts, Mamodikoe Makhene, James D. Chappell, Mark R. Denison, Laura J. Stevens, Andrea J. P. Pruijssers, Adrian B. McDermott, Britta Flach, Bob C. Lin, Nicole A. Doria‐Rose, Sijy O’Dell, Stephen D. Schmidt, Kathleen Maletic Neuzil, Hamilton Bennett, Brett A. Leav, Mat Makowski, Jim Albert, Kaitlyn Cross, Venkata Viswanadh Edara, Katharine A. Floyd, Mehul S. Suthar, Wendy L. Buchanan, Catherine J. Luke, Julie E. Ledgerwood, John R. Mascola, Barney S. Graham, John H. Beigel · 发表于：New England Journal of Medicine · 年份：2020 · DOI：10.1056/nejmc2032195 · 被引用次数：831 · 研究领域：SARS-CoV-2 and COVID-19 Research、Animal Virus Infections Studies、Immunotherapy and Immune Responses

Immunogenicity and the mRNA-1273 SARS-CoV-2 Vaccine Thirty-four adults received two 100-μg injections of the mRNA-1273 SARS-CoV-2 vaccine, and serum anti–spike protein and neutralizing antibody tit...